文献速递肾小球疾病

IgA肾病患者血浆聚合型IgA1的O-糖基化形式与病理表型相关

O-glycoforms of polymeric immunoglobulin A1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes.
PubMed 文献 · Nephrol Dial Transplant · 2021-01-01

该研究分析了IgA肾病患者血浆聚合型IgA1铰链区O-糖基化形式,发现IgA肾病患者GalNAc结合数低于健康对照,且新月体型患者GalNAc3和GalNAc4比例最高、GalNAc5和GalNAc6最低,提示O-糖基化形式可能与新月体形成相关。

要点

  • IgA肾病患者pIgA1铰链区GalNAc结合数低于健康对照。
  • 新月体型IgA肾病患者GalNAc3和GalNAc4比例最高,GalNAc5和GalNAc6最低。
  • GalNAc数量随新月体比例增加而减少,可能与严重表型相关。

核心结论

  • IgA肾病患者IgA1铰链区GalNAc数量降低,尤其在新月体型患者中,可能与严重IgA肾病表型相关。

研究设计与样本

  • 发现队列(队列1)含11例新月体型IgA肾病患者、10例非新月体型患者和10例健康对照。
  • 验证队列(队列2)含11例新月体型IgA肾病患者、9例非新月体型患者和9例健康对照。
  • 另纳入143例不同新月体比例的IgA肾病患者(队列3),从血浆纯化pIgA1,用液相色谱-串联质谱评估O-糖基化形式。

主要发现

  • 队列1中,IgA肾病患者每个铰链区结合的GalNAc数低于健康对照。
  • 队列1中,GalNAc3比例在新月体型、非新月体型和健康对照分别为9.92±3.37%、6.65±1.53%和4.05±1.24%(P<0.001)。
  • 队列1中,GalNAc4比例在三组分别为45.91±4.75%、41.13±2.95%和40.98±2.95%(P=0.004)。
  • 队列1中,GalNAc5比例在三组分别为50.15±4.27%、47.92±4.09%和45.87±3.79%(P=0.028);GalNAc6比例分别为6.58±2.53%、6.04±1.35%和4.65±2.27%(P=0.034)。
  • 队列2结果与队列1一致;队列3中pIgA1的GalNAc数量随新月体比例增加而减少。

临床怎么用

  • 血浆pIgA1的O-糖基化形式(如GalNAc3/4比例升高、GalNAc5/6比例降低)可能作为IgA肾病新月体形成的无创生物标志物。

局限性

  • 原文未报告队列3的具体统计比较结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Immunoglobulin A1 (IgA1) O-glycosylation plays an important role in the pathogenesis of IgA nephropathy (IgAN). However, variations in IgA1 O-glycoforms have not been explored. We aimed to investigate the IgA1 O-glycoforms in the hinge region (HR) of polymeric IgA1 (pIgA1) and then evaluate the association between IgA1 O-glycoforms and crescent formation in IgAN. METHODS: The discovery cohort (Cohort 1) comprised 11 crescentic IgAN patients, 10 noncrescentic IgAN patients and 10 healthy controls and the validation cohort (Cohort 2) comprised 11 crescentic IgAN patients, 9 noncrescentic IgAN patients and 9 healthy controls. A total of 143 IgAN patients with different crescent percentages (Cohort 3) were also included. pIgA1 was purified from the plasma of the participants. The variation in O-glycoforms was evaluated by estimating the molecular weights of IgA1 hinge glycopeptides using reversed-phase liquid chromatography and tandem mass spectrometry under electron-transfer/higher-energy collision dissociation fragmentation mode. RESULTS: In the discovery cohort (Cohort 1), the number of N-acetylgalactosamine (GalNAc) bound to one HR was lower in IgAN patients. The proportions of GalNAc3 (defined as O-glycans bound to one HR at three sites) and GalNAc4 were highest in crescentic IgAN patients, followed by noncrescentic IgAN patients, and were lowest in healthy controls [GalNAc 3: 9.92 ± 3.37% versus 6.65 ± 1.53% versus 4.05 ± 1.24% (P < 0.001); GalNAc4: 45.91 ± 4.75% versus 41.13 ± 2.95% versus 40.98 ± 2.95% (P = 0.004), respectively]. The proportions of GalNAc5 and GalNAc6 were lowest in crescentic IgAN patients followed by noncrescentic IgAN patients and were highest in healthy controls [GalNAc5: 50.15 ± 4.27% versus 47.92 ± 4.09% versus 45.87 ± 3.79% (P = 0.028); GalNAc6: 6.58 ± 2.53% versus 6.04 ± 1.35% versus 4.65 ± 2.27% (P = 0.034), respectively]. These results were consistent in the validation cohort (Cohort 2). In another cohort with 143 patients with different crescent percentages (Cohort 3), the number of GalNAc in pIgA1 decreased with an increasing percentage of crescents. CONCLUSIONS: The number of GalNAc in IgA1 HRs was lower in IgAN patients, especially in crescentic IgAN patients, and may be associated with a severe IgAN phenotype.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Yu G, Zhang Y, Meng B, et al. O-glycoforms of polymeric immunoglobulin A1 in the plasma of patients with IgA nephropathy are associated with pathological phenotypes. Nephrol Dial Transplant. 2021. PMID: 34152412. doi:10.1093/ndt/gfab204

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。